Literature DB >> 11753094

Expression, regulation and function of carrier proteins for cationic amino acids.

Ellen I Closs1.   

Abstract

Different carrier proteins exhibiting distinct transport properties participate in cationic amino acid transport. There are sodium-independent systems, such as b+, y+, y+L and b0,+, and a sodium-dependent system B0,+, most of which have now been identified at the molecular level. In most non-epithelial cells, members of the cationic amino acid transporter (CAT) family mediating system y+ activity seem to be the major entry pathway for cationic amino acids. CAT proteins underlie complex regulation at the transcriptional, post-transcriptional and activity levels. Recent evidence indicates that individual CAT isoforms are necessary for providing the substrate for nitric oxide synthesis, for example CAT-1 for Ca2+-independent nitric oxide production in endothelial cells and CAT-2B for sustained nitric oxide production in macrophages.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11753094     DOI: 10.1097/00041552-200201000-00015

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  18 in total

Review 1.  Structure and function of cationic amino acid transporters (CATs).

Authors:  E I Closs; J-P Boissel; A Habermeier; A Rotmann
Journal:  J Membr Biol       Date:  2007-04-06       Impact factor: 1.843

Review 2.  CATs and HATs: the SLC7 family of amino acid transporters.

Authors:  François Verrey; Ellen I Closs; Carsten A Wagner; Manuel Palacin; Hitoshi Endou; Yoshikatsu Kanai
Journal:  Pflugers Arch       Date:  2003-06-11       Impact factor: 3.657

3.  L-arginine stimulates CAT-1-mediated arginine uptake and regulation of inducible nitric oxide synthase for the growth of chick intestinal epithelial cells.

Authors:  Chao Yuan; Xiaoyun Zhang; Qiang He; Junming Li; Jianjun Lu; Xiaoting Zou
Journal:  Mol Cell Biochem       Date:  2014-10-22       Impact factor: 3.396

4.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

5.  Protein kinase C-dependent ubiquitination and clathrin-mediated endocytosis of the cationic amino acid transporter CAT-1.

Authors:  Arnau Vina-Vilaseca; Julia Bender-Sigel; Tatiana Sorkina; Ellen Ildicho Closs; Alexander Sorkin
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

6.  Expression of solute carrier 7A4 (SLC7A4) in the plasma membrane is not sufficient to mediate amino acid transport activity.

Authors:  Sabine Wolf; Annette Janzen; Nicole Vékony; Ursula Martiné; Dennis Strand; Ellen I Closs
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

7.  Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport.

Authors:  Chunying Li; Wei Huang; M Brennan Harris; Jonathan M Goolsby; Richard C Venema
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

8.  Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium.

Authors:  Jessica L Lowry; Viktor Brovkovych; Yongkang Zhang; Randal A Skidgel
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

9.  The hnRNA-binding proteins hnRNP L and PTB are required for efficient translation of the Cat-1 arginine/lysine transporter mRNA during amino acid starvation.

Authors:  Mithu Majumder; Ibrahim Yaman; Francesca Gaccioli; Vladimir V Zeenko; Chuanping Wang; Mark G Caprara; Richard C Venema; Anton A Komar; Martin D Snider; Maria Hatzoglou
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

Review 10.  Cellular ADMA: regulation and action.

Authors:  Tom Teerlink; Zaiming Luo; Fredrik Palm; Christopher S Wilcox
Journal:  Pharmacol Res       Date:  2009-08-12       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.